300683 海特生物
按盤價 
27.730 -0.340 (-1.211%)
27.730 -0.340 (-1.211%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -6.836 | -2.848 | -5.046 | -0.605 | 1.371 |
| 總資產報酬率 ROA (%) | -5.673 | -2.348 | -4.256 | -0.519 | 1.132 |
| 投入資產回報率 ROIC (%) | -6.372 | -2.617 | -4.602 | -0.554 | 1.211 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.813 | 42.846 | 42.709 | 48.465 | 56.922 |
| 營業利潤率 (%) | -39.957 | -11.666 | -23.755 | -0.991 | 3.472 |
| 息稅前利潤/營業總收入 (%) | -41.617 | -13.140 | -26.421 | -2.769 | 1.288 |
| 淨利潤/營業總收入 (%) | -38.133 | -11.367 | -21.293 | -1.147 | 4.883 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 53.046 | 114.200 | 73.686 | 33.176 | 62.355 |
| 價值變動淨收益/利潤總額(%) | -11.772 | -19.703 | -11.570 | -303.115 | 68.468 |
| 營業外收支淨額/利潤總額(%) | 1.916 | 5.528 | 5.864 | 12.800 | -4.321 | 償債能力分析 |
| 流動比率 (X) | 4.598 | 3.596 | 4.299 | 5.072 | 6.349 |
| 速動比率 (X) | 4.250 | 3.296 | 3.960 | 4.650 | 6.062 |
| 資產負債率 (%) | 14.907 | 17.879 | 16.011 | 13.732 | 13.140 |
| 帶息債務/全部投入資本 (%) | 0.132 | 1.375 | 5.182 | 6.808 | 6.115 |
| 股東權益/帶息債務 (%) | 71,160.955 | 6,750.464 | 1,756.515 | 1,342.007 | 1,498.597 |
| 股東權益/負債合計 (%) | 568.235 | 455.539 | 520.916 | 621.573 | 655.765 |
| 利息保障倍數 (X) | 47.299 | 16.610 | 22.283 | 1.696 | -0.631 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.416 | 31.912 | 34.293 | 41.732 | 62.172 |
| 存貨周轉天數 (天) | 106.888 | 109.866 | 123.943 | 97.300 | 96.042 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
